Stocks-GSK.L-GlaxoSmithKline

GSK.L GlaxoSmithKline

0 0 (0%)
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: GlaxoSmithKline's revenues increased by 3.42% and amounted to 30.33B. Net income increased by 7.86% to 5.31B. Net assets decreased by NaN to N/A and EPS decreased from 3.66 to N/A.
GSK.L's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
72.21%
Net Profit Margin
15.10%
Operating Margin
22.13%
Return On Investment
14.22%